PERIPHAGEN
PeriphaGen is a biopharmaceutical company whose corporate objective is the development of first in class neuronal gene delivery products for neurologic disorders with significant unmet medical need. The intuitive way to treat conditions that directly affect neurons is to target treatment to the neurons themselves. PeriphaGen's first indications of interest are neuropathic pain, neuropathy, and neuronal regeneration. The PeriphaGen NEuronal Therapeutics (NET) platform based drug candidates hav... e the ability to express therapeutic proteins directly and specifically in neurons for four to eight weeks after a simple intradermal application. NET products express natural gene products locally that block pain signaling, protect against neuronal damage, or promote neuronal regeneration without systemic side effects.
PERIPHAGEN
Industry:
Biotechnology Genetics Medical Device Pharmaceutical
Founded:
2012-01-01
Address:
Pittsburgh, Pennsylvania, United States
Country:
United States
Website Url:
http://www.periphagen.com
Total Employee:
1+
Status:
Active
Contact:
(412)488-0348
Total Funding:
6.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon Content Delivery Network Euro GStatic Google Static Content Wix
Similar Organizations
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Dnaprint Genomics
DNAPrint Genomics is a genetics company with a wide range of products related to genetic profiling, forensic & consumer genomics products.
NewBridge Pharmaceuticals
Newbridge Pharmaceuticals is a pharmaceutical and medical device company engaged in developing oncology and supportive care products.
Sebela Pharmaceuticals
Sebela is committed to improving patients’ lives by developing, marketing and selling differentiated branded prescription pharmaceuticals.
Current Advisors List
Board_member
2014-02-01
Current Employees Featured
James Wechuck Chief Scientific Officer, Founder @ PeriphaGen
Chief Scientific Officer, Founder
David Krisky Chief Medical Officer, Founder @ PeriphaGen
Chief Medical Officer, Founder
Darren Wolfe Chief Executive Officer, Founder @ PeriphaGen
Chief Executive Officer, Founder
Founder
Official Site Inspections
http://www.periphagen.com
- Host name: 147.62.236.23.bc.googleusercontent.com
- IP address: 23.236.62.147
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "PeriphaGen"
Periphagen
Periphagen is a biopharmaceutical company focused on the development of herpes simplex virus type I (HSV-1) as a gene therapy vector. Our primary focus is the use of HSV-1 vectors for …See details»
PeriphaGen - Crunchbase Company Profile & Funding
PeriphaGen is a biopharmaceutical company whose corporate objective is the development of first in class neuronal gene delivery products for neurologic disorders with significant unmet …See details»
OUR TEAM - periphagen
Prior to founding PeriphaGen Dr. Krisky was the Senior Director of Medical Science and Clinical Safety for Diamyd Incorporated and was responsible for the product development and clinical …See details»
PeriphaGen Inc - LinkedIn
PeriphaGen is a biopharmaceutical company focused on peripheral nerve gene therapy and committed to the development of innovative products for difficult-to-treat neurological disorders thereby ...See details»
PeriphaGen 2025 Company Profile: Valuation, Investors …
PeriphaGen General Information Description. Operator of a biopharmaceutical company headquartered in Pittsburgh, Pennsylvania. The company develops …See details»
PeriphaGen - The Org
PeriphaGen is a biopharmaceutical company focused on peripheral nerve gene therapy and committed to the development of innovative products for difficult-to-treat neurological disorders …See details»
Periphagen Company Profile - Craft
Periphagen is a biopharmaceutical company focused on peripheral nerve gene therapy for disorders such as neuropathy and chronic pain. It provides a Neuronal Therapeutics (NET) …See details»
PeriphaGen Inc Overview | SignalHire Company Profile
PeriphaGen Inc is a private company that has been in the industry for 11 years. The company currently specializes in the Pharmaceuticals area. ... Organization Website: periphagen.com : …See details»
PeriphaGen Holdings - VentureRadar
Periphagen is a biopharmaceutical company focused on the development of herpes simplex virus type I (HSV-1) as a gene therapy vector. Our primary focus is the use of HSV-1 vectors for …See details»
PeriphaGen - Contacts, Employees, Board Members, Advisors
PeriphaGen is a biopharmaceutical company whose corporate objective is the development of first in class neuronal gene delivery products. Search Crunchbase. Start Free Trial . Chrome …See details»
CONTACT US - periphagen
PeriphaGen, Inc. 2403 Sidney Street. Suite 255 Pittsburgh, PA 15203 . Success! Message received. Send. PeriphaGen is interested in speaking with potential corporate (pharma) …See details»
PeriphaGen (Herpes Drug Development Platform and …
PeriphaGen (Herpes Drug Development Platform and Manufacturing Expertise) was acquired by Candel Therapeutics. Data Transparency. Meet our data hygiene team. Discover how our …See details»
PeriphaGen - Funding, Financials, Valuation & Investors
PeriphaGen is a biopharmaceutical company whose corporate objective is the development of first in class neuronal gene delivery products. ... Experience the new Crunchbase, powered by …See details»
Periphagen Holdings, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Periphagen Holdings, Inc. with its drug pipeline, therapeutic area, technology platform, , Disease Domain:Nervous System Diseases, Technology Platform:Gene ...See details»
PeriphaGen - Company profile | ensun
PeriphaGen is a biopharmaceutical company focused on peripheral nerve gene therapy and committed to the development of innovative products for difficult-to-treat neurological …See details»
Periphagen - Overview, News & Similar companies | ZoomInfo.com
Oct 22, 2018 Krystal Biotech Announces Settlement with PeriphaGen, Inc. PITTSBURGH, March 15, 2022 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc., (“Krystal”) (NASDAQ: KRYS), …See details»
Periphagen Inc Company Information - Funding, Investors, and More
Track over 71,000 companies. Discover Fast-growing Global startups. Seedtable uses technology and people to track over 71,000 companies to help you find the right ones to partner with.See details»
OUR TECHNOLOGY - periphagen
PeriphaGen is a biopharmaceutical company focused on peripheral nerve gene therapy and committed to the development of innovative products for difficult-to-treat neurological …See details»
Transfer of youth-serving organization The Link to Brokenhead …
19 hours ago The operation of The Link is being shifted from a not-for-profit organization that relied heavily on government funding to being owned and led by Brokenhead Ojibway Nation. …See details»
OUR PIPELINE - periphagen
PeriphaGen’s NET vector technology allows for targeted delivery to specific sensory nerves via a simple intradermal skin injection, thus our lead products have focused on treating peripheral …See details»